AzTrials
AzTrials

Spinal Cord InjuryNCT07222033

Self-balancing Personal Exoskeleton for SCI (WINY)

A study testing Hands-free exoskeleton in people with Spinal Cord Injury and Paraplegia and Tetraplegia, run by Wandercraft at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI). Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Hands-free exoskeleton
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteUnited States
Study dates
11 Aug 2025to 31 May 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

SCI user inclusion Criteria:

  • Any gender, age 18 years or older;
  • Motor complete or incomplete SCI with lesions at or above T6;
  • ≥ 6 months post SCI;
  • Able and willing to attend 9 to 10 visits1 to the center, including sessions of training and assessments of one-to-three hours duration;
  • Able to read, understand, and provide informed consent;
  • Living in the US and speaks English.

SCI user exclusion Criteria:

  • Diagnosis of neurological injury other than SCI;
  • Progressive condition that would be expected to result in changing neurological status;
  • Severe concurrent medical disease, illness or condition judged to be contraindicated by the site physician;
  • Unhealed or unstable traumatic or high impact lower extremity fracture of any duration that is, in the clinical judgement of the study physician, exclusionary for standing and walking;
  • Knee (proximal tibia and/or distal femur) BMD <0.60 gm/cm2;
  • Total hip BMD T-scores < -3.5;
  • Fragility, minimal trauma, or low impact fracture of the lower extremity since SCI;
  • Untreatable severe spasticity judged to be contraindicated by the site physician;
  • Untreated/uncontrolled hypertension, as judged to be contraindicated by the site physician;
  • Unresolved orthostatic hypotension (change from baseline seated BP to a fall in 20mmHg SBP and/or fall in 10mmHG DBP and symptoms when standing), or as judged to be contraindicated by the site physician;
  • Open or unhealed skin pressure sores, abrasions, or bruises at any of the contact points of the exoskeleton;
  • Morphological contraindications to the use of the device;
  • Uncorrectable leg length discrepancy over 2 cm (about 0.79 in) when using additional correction tools;
  • Unable to effectively operate the device with a hand-control interface, due to functional and/or cognitive impairment, evaluated based on the ability to manipulate the joystick in all direction, press and identify buttons on the hand control interface.
  • Improper fitting in the device;
  • Psychopathology documentation in the medical record that may conflict with study objectives;
  • Pregnancy or women who plan to become pregnant during the study period;
  • Concurrent participation in another interventional trial;
  • History of uncontrolled autonomic dysreflexia;
  • Presence colostomy and/or urostomy;
  • Ventilator use at the time of the exoskeleton use;

Companion inclusion Criteria:

  • Any gender, age 18 years or older;
  • Willingness to attend 9 to 10 visits to the center, including sessions of training and assessments of one-to-three hours duration with the SCI user;
  • Able to read, understand and provide informed consent;
  • Living in the US and speaks English.

Companion exclusion Criteria:

  • Inability to communicate with an assistant due to cognitive and language disorders;
  • Any disease, concomitant injury, or condition that interferes with the performance or interpretation of the protocol- specified assessments;
  • Insufficient strength and performance capability, evidenced by the ability to hold and retain the device in case of unbalance/fall;
  • Insufficient availability to complete the study;
  • Concurrent participation in another interventional trial.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Joshua Breighner, PT DPT contact

646-448-4787

Joshua.breighner@winypt.health

United States1 site, 1 recruiting
  • Walk in New York (WINY) Physical Therapy, P.C.

    New York, New York, 10010

    Joshua Breighner, PT DPT, 646-448-4787, Joshua.breighner@winypt.health

    Joshua Breighner, PT DPT

    Recruiting

Other trials in United States

About this study

Official title: Empowering Mobility in People With Spinal Cord Injury With a Hands-free, Self-balancing Personal Exoskeleton

This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).

Read the detailed description

This personal exoskeleton, developed by Wandercraft as a new version of the Atalante X, offers a novel hands-free and self-balancing design, aiming at enhancing stability and mobility for users in daily activities.

The study features an interventional, prospective, single-group, and open-label design, conducted over 3 to 4 weeks in a US investigation site. It aims to enroll up to 12 SCI users and their 12 companions, resulting in 12 SCI user-companion pairs.

Over the course of nine to ten scheduled visits, participants undergo a sequence of procedures, beginning with screening and device fitting. This is followed by five training sessions which conclude with an evaluation to issue a competency certificate to confirm the ability to use the device across all its "basic skills". Additionally, two sessions are dedicated to evaluating the exoskeleton's effectiveness outcomes, complemented by an extra practice session. Each visit lasts an average of 1.5 hours.

Being tested
Hands-free exoskeleton
Keywords
Spinal Cord Injury, Robotics, Community use, Hands-free exoskeleton, Overground exoskeleton, Walking, Self-balancing
Medical subject headings
Spinal Cord Injuries, Paraplegia, Quadriplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hands-free exoskeletonDevice

    A "device trainer specialist" from the investigation site will deliver training sessions with the exoskeleton to pair of participants (a pair corresponds to an individual with SCI and his/her companion). The device trainer will follow the progression of the pair through the training program and ensure they learn all the device "basic skills". Each training session lasts an average of 1.5 hours, variations according to the user's learning pace and tolerance. During the sessions with the exoskeleton, the participants will engage in mobility activities on different surfaces and perform Activities of Daily Living in simulated environments such as kitchen, bathroom, elevators and outdoor spaces.

Study groups in NCT07222033
Study groupRoleWhat they receive
Hands-free exoskeletonExperimentalNot described
Receives: Device: Hands-free exoskeleton

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Safety of the device for its intended use and user population.

    Collection and analysis of adverse events to evaluate the safety of the device for its intended use and user population, specifically for individuals with spinal cord injury (SCI) performing ambulatory activities hands-free, accompanied by a companion.

    Measured: Throughout the study and up until the end of Visit 9, after an average of 9 hours of training and 3 hours of assessment.

Secondary outcomes (5)
  1. Proportion of subjects who complete the Timed Up and Go (TUG) in 3min or less.

    The TUG evaluates the time from starting in a seated position to stand-up, walk 3 meters, turn around, walk back 3 meters and sit down on indoor surface.

    Measured: After a mean of 7.5 hours of training and a mean of 9 hours of training.

  2. Proportion of subjects who complete a distance of at least 40m on the Six-Minute Walk Test (6MWT).

    The 6MWT measures the distance in meters traversed over 6 min, on indoor surface.

    Measured: After a mean of 7.5 hours of training and a mean of 9 hours of training.

  3. Proportion of subjects who can complete at least 4 out of the 6 Activities of Daily Living (ADLs), in various simulated environments and with the exoskeleton.

    The ADLs are done standing in front of the countertop in the kitchen, in a simulated living room, taking a 50m walk in the outdoor environment, taking the elevator, in the bathroom and walking in a hallway and through a door to get to the next room.

    Measured: After a mean of 7.5 hours of training and a mean of 9 hours of training.

  4. Proportion of subjects who complete the 10-Meter Walk Test (10MWT) on indoor surfaces in 1 minute or less.

    The 10MWT measures the time in seconds taken to walk 10 meters.

    Measured: After a mean of 7.5 hours of training and a mean of 9 hours of training.

  5. Proportion of subjects who can don or doff the device within 10 minutes each, separately.

    Measured: After a mean of 7.5 hours of training and a mean of 9 hours of training.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2025
  2. Study start11 Aug 2025
  3. Primary completion31 May 2026 (estimated)
  4. Study completion31 May 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
12 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07222033
Sponsor's protocol ID
CIP007 WINY
Status last verified
Jan 2026
First submitted
14 Oct 2025
Last updated
2 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Hands-free exoskeleton in people with Spinal Cord Injury and Paraplegia and Tetraplegia, run by Wandercraft at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Joshua Breighner, PT DPT (646-448-4787, Joshua.breighner@winypt.health), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Safety of the device for its intended use and user population. (time frame: Throughout the study and up until the end of Visit 9, after an average of 9 hours of training and 3 hours of assessment.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in